Richard Mularski to Aged
This is a "connection" page, showing publications Richard Mularski has written about Aged.
Connection Strength
0.613
-
Medical Record Quality Assessments of Palliative Care for Intensive Care Unit Patients. Do They Match the Perspectives of Nurses and Families? Ann Am Thorac Soc. 2016 05; 13(5):690-8.
Score: 0.062
-
Family members' views on the benefits of harp music vigils for terminally-ill or dying loved ones. Palliat Support Care. 2015 Feb; 13(1):41-4.
Score: 0.052
-
Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J Altern Complement Med. 2009 Oct; 15(10):1083-90.
Score: 0.039
-
The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006 Dec; 130(6):1844-50.
Score: 0.032
-
End-of-life care in the critically ill geriatric population. Crit Care Clin. 2003 Oct; 19(4):789-810, viii.
Score: 0.026
-
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1365-1376.
Score: 0.023
-
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations. Int J Chron Obstruct Pulmon Dis. 2021; 16:2755-2767.
Score: 0.023
-
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021 03 04; 384(9):795-807.
Score: 0.021
-
Association between self-reported moderate to vigorous physical activity and the rate of outpatient treated COPD exacerbations: retrospective cohort study. BMJ Open Respir Res. 2020 05; 7(1).
Score: 0.021
-
Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2020 02; 7(1).
Score: 0.020
-
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling. Health Qual Life Outcomes. 2019 Dec 19; 17(1):186.
Score: 0.020
-
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019 12 01; 200(11):1354-1362.
Score: 0.020
-
Protocol for a Noninferiority Comparative Effectiveness Trial of Home-Based Palliative Care (HomePal). J Palliat Med. 2019 09; 22(S1):20-33.
Score: 0.020
-
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment. BMJ Open. 2019 08 30; 9(8):e028438.
Score: 0.020
-
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
Score: 0.019
-
Nonsurgical causes of pneumoperitoneum. West J Med. 1999 Jan; 170(1):41-6.
Score: 0.019
-
Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2017 Dec; 14(12):1836-1843.
Score: 0.017
-
Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respir Med. 2017 02; 123:124-130.
Score: 0.016
-
Family Perspectives on Overall Care in the Intensive Care Unit. Nurs Res. 2016 Nov/Dec; 65(6):446-454.
Score: 0.016
-
Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial. Am J Prev Med. 2016 10; 51(4):609-19.
Score: 0.016
-
Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 09; 13(9):1490-6.
Score: 0.016
-
A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015 Sep; 46(3):651-62.
Score: 0.014
-
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014 Nov 01; 190(9):989-95.
Score: 0.014
-
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol. 2014 Oct; 21(4):288-97.
Score: 0.014
-
Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form. BMC Med Res Methodol. 2014 Jun 16; 14:78.
Score: 0.014
-
Long-term persistence of quality improvements for an intensive care unit communication initiative using the VALUE strategy. J Crit Care. 2014 Jun; 29(3):450-4.
Score: 0.013
-
Development, validation, and results of a risk-standardized measure of hospital 30-day mortality for patients with exacerbation of chronic obstructive pulmonary disease. J Hosp Med. 2013 Aug; 8(8):428-35.
Score: 0.013
-
Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals: study protocol for a randomized controlled trial. Trials. 2012 Aug 01; 13:129.
Score: 0.012